Author Archives for Adeline Chauvigné

Vincent Procaccio – Head of the Department of Genetics at Angers University Hospital, joins KetoM+

14 June 2025

His remarkable professional skills and personality will be a great addition to our team and a critical asset for the... View Article

Pherecydes Pharma obtains ANSM approval for its PhagoDAIR program, the world’s first study in precision phage therapy

14 June 2025

PhagoDAIR is a phase I/II clinical study with anti-Staphylococcus aureus phages in the treatment of osteoarticular infections of prostheses caused... View Article

Valneva announces positive lot-to-lot consistency trial results for its single-shot Chikungunya vaccine candidate

14 June 2025

Valneva, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine... View Article

Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU)

14 June 2025

Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU) Olivier... View Article

Valneva announces positive homologous booster data for inactivated, adjuvanted COVID-19 vaccine candidate VLA

14 June 2025

Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8 months after the second dose... View Article

Pherecydes Pharma continues to strengthen its intellectual property with a first patent granted in China

14 June 2025

Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced the granting... View Article

New member | AbolerIS Pharma

14 June 2025

AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in... View Article

New member | THERADEV

THERADEV develops solutions composed of phytogenic active ingredients for the prevention of metabolic diseases.  Find out more about THERADEV: www.theradev.fr 

Rédigé par Adeline Chauvigné, le 2021-12-14

New member | THERADEV

14 June 2025

THERADEV develops solutions composed of phytogenic active ingredients for the prevention of metabolic diseases.  Find out more about THERADEV: www.theradev.fr 

New member | Theradev

14 June 2025

Theradev specialises in the research and development of innovative solutions for the regulation of major metabolic disorders. Thanks to its... View Article

ABYS® MEDICAL successfully completes its first Series A of €3 million

14 June 2025

Abys® Medical, deeptech creator of the Surgery 4.0 concept, finalized in August 2021 a fundraising by opening its capital to... View Article